Animal Health
(NP #103)
|
|
Elucidating the Pathobiology and Transmission of Transmissible Spongiform Encephalopathies
(In-House Appropriated)
|
|
Intervention Strategies to Control Endemic and New and Emerging Influenza A Virus Infections in Swine
(In-House Appropriated)
|
|
Intervention Strategies to Control Endemic and New Emerging and Re-Emerging Viral Diseases of Swine
(In-House Appropriated)
|
|
Virulence Mechanisms, Microbiome Changes and Control Strategies for Priority Bacterial Infections in Swine
(In-House Appropriated)
|
|
Online Algorithms to Identify Reassortment and Genetic Novelty in Genomic Influenza A Virus Surveillance Data
(Cooperative Agreement)
|
|
Development of Vaccines for HPAI in Pigs Related to HPAI Virus in Food Products (HPAI Natural Course of Disease)
(Interagency Reimbursable Agreement)
|
|
Development of Vaccines for HPAI in Pigs Related to HPAI Virus in Food Products (Swine Studies)
(Interagency Reimbursable Agreement)
|
|
Response to APHIS SARS-CoV-2 Research Priorities Phase 1 (VPR)
(Interagency Reimbursable Agreement)
|
|
The Study of Influenza A Viruses in the Swine Host
(Interagency Reimbursable Agreement)
|
|
The Study of Influenza A Viruses in the Swine Host
(Interagency Reimbursable Agreement)
|
|
USDA Influenza A Virus in Swine Surveillance System – Genomic Epidemiology and Evolution
(Interagency Reimbursable Agreement)
|
|
Assessment of Biochar- Chronic Wasting Disease Interactions and the Feasibility of Using Biochar to Reduce Spread of Chronic Wasting Disease
(Non-Funded Cooperative Agreement)
|
|
Defining Antagonism Hierarchy of Porcine Epidemic Diarrhea Virus for Live Vaccines Design
(Reimbursable Cooperative Agreement)
|
|
Mechanisms of Differential Pathogenesis and Risk Among Mammalian Isolates of Highly Pathogenic Avian Influenza A (H5N1) Strains in Swine
(Reimbursable Cooperative Agreement)
|
|
mRNA-LNP Vaccines for Pandemic Preparedness
(Reimbursable Cooperative Agreement)
|
|
NIAID Centers of Excellence for Influenza Research and Response
(Reimbursable Cooperative Agreement)
|
|
Safe and Broadly Cross-Protective Live Attenuated Influenza Virus Vaccine for Use in Swine
(Reimbursable Cooperative Agreement)
|
|
Transmission Bottlenecks and Within-host Evolutionary Dynamics of Influenza A Virus
(Reimbursable Cooperative Agreement)
|
|
Algorithms to Identify Novel Influenza A Viruses in Genomic Surveillance Data
(Non-Assistance Cooperative Agreement)
|
|
Assessing the Potential Transmissibility of Bovine and Cervid Prions with a Human Prion Protein-based Model
(Non-Assistance Cooperative Agreement)
|
|
Characterization of Influenza at the Human and Swine Interface
(Non-Assistance Cooperative Agreement)
|
|
Development of Wireless Sensors for Detecting Misfolded Prion Proteins and Rumen pH of Deer
(Non-Assistance Cooperative Agreement)
|
|
Evolution of Influenza A Virus in Swine in Brazil
(Non-Assistance Cooperative Agreement)
|
|
Pathogenesis of Swine Acute Diarrhea Syndrome Coronavirus
(Non-Assistance Cooperative Agreement)
|
|
Efficacy of a Pan-genotypic Influenza A Virus Antisense Locked Nucleic Acid Oligonucleotide (LNA) as a Preventative and Therapeutic in Swine
(Trust Fund Cooperative Agreement)
|
|
In Vivo Evaluation of Avirulent Live B. Bronchiseptica Vaccine to Reduce PRDC Severity
(Trust Fund Cooperative Agreement)
|